Selected as a participating institution for the Japan Agency for Medical Research and Development (AMED) FY2023 “Startup Problem-Solving Support Program by Young Researchers.”
InnoJin Inc., a venture company originating from Juntendo University, jointly applied with Juntendo University, Imacreate Inc., and Sumitomo Corporation for the "FY2023 Startup Problem-Solving Support Program by Young Researchers" publicly offered by the Japan Agency for Medical Research and Development (AMED), and was selected (InnoJin Inc. participated as a partner institution).